Search Results - "Landonio, S"

Direct Acting Antivirals in patients with HCV-associated mixed cryoglobulinemia: real life safety and efficacy by Rizzardini, G, Schiavini, M, Niero, F, Magni, C, Landonio, S, Iemoli, E, Bolis, M, Colaneri, M, Gubertini, G

Get full text

P1168 ITPA AND SLC29A1 GENOTYPING BEFORE TRIPLE THERAPY PREDICT SEVERITY OF RIBAVIRIN-INDUCED ANEMIA by Milazzo, L, Landonio, S, Magni, C, Gervasoni, C, Calvi, E, Cheli, S, Clementi, E, Galli, M, Falvella, F.S

Get full text

The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution by Cento, V, Barbaliscia, S, Di Maio, V.C, Masetti, C, Minichini, C, Magni, C.F, Micheli, V, Marenco, S, Nicolini, L.A, Bruzzone, B, Troshina, Y, Baiguera, C, Dentone, C, Calvaruso, V, Paolucci, S, Melis, M, Aragri, M, Bertoli, A, Lenci, I, Landonio, S, Schiavini, M, Sticchi, L, Ruggiero, T, Polilli, E, Messina, V, Pellicelli, A, Boglione, L, Cozzolongo, R, Biolato, M, Morisco, F, Siciliano, M, Parruti, G, Barbarini, G, Craxì, A, Babudieri, S, Puoti, M, Ciancio, A, Rizzardini, G, Coppola, N, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Integrated full line of mechanization for vineyard preparation by Mazzetto, F, Gallo, R, Calcante, A, Landonio, S, Lazzari, M

“…It is well known that in an increasingly globalizing economy the competitiveness of the wine sector is obtainable through effective marketing policies and the…”
Get full text

The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network by Cento, V, Barbaliscia, S, Di Maio, V.C, Masetti, C, Minichini, C, Magni, C.F, Micheli, V, Marenco, S, Nicolini, L.A, Bruzzone, B, Troshina, Y, Baiguera, C, Dentone, C, Calvaruso, V, Paolucci, S, Melis, M, Aragri, M, Bertoli, A, Lenci, I, Landonio, S, Schiavini, M, Sticchi, L, Ruggiero, T, Polilli, E, Messina, V, Pellicelli, A, Boglione, L, Cozzolongo, R, Biolato, M, Morisco, F, Siciliano, M, Parruti, G, Barbarini, G, Craxì, A, Babudieri, S, Puoti, M, Ciancio, A, Rizzardini, G, Coppola, N, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Antiretroviral treatment and age‐related comorbidities in a cohort of older HIV‐infected patients by Orlando, G, Meraviglia, P, Cordier, L, Meroni, L, Landonio, S, Giorgi, R, Fasolo, M, Faggion, I, Riva, A, Zambelli, A, Beretta, R, Gubertini, G, Dedivitiis, G, Jacchetti, G, Cargnel, A

“…Background The availability of several therapeutic regimens has transformed HIV infection from a life‐threatening disease into a chronic condition. Older…”
Get full text

P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS by Cento, V, Di Maio, V.C, Di Paolo, D, Micheli, V, Tontodonati, M, De Leonardis, F, Aragri, M, Antonucci, F.P, Mancon, A, Armenia, D, Bellocchi, M.C, Lenci, I, Manunta, A, Taliani, G, Di Biagio, A, Nicolini, L.A, Nosotti, L, Sarrecchia, C, Siciliano, M, Landonio, S, Pellicelli, A, Gasbarrini, A, Vecchiet, J, Magni, C.F, Babudieri, S, Mura, M.S, Andreoni, M, Parruti, G, Rizzardini, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey by Bruno, S, Bollani, S, Zignego, A.L, Calvaruso, V, Magni, C, Landonio, S, Rizzetto, M, Ciancio, A, Mangia, A, Piazzolla, V, Caremani, M, Piovesan, S, Cavalletto, L, Babudieri, S, Moretti, A, Colletta, C, Massari, M, Fangazio, S, Mazzotta, F, Muratori, L, Colombo, A.E, Zuin, M, Traverso, A, Santantonio, T, Farina, F, Marchionne, E, Serviddio, G, Russello, M, Licata, A, Craxì, A, Di Marco, V

Get full text

Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors by Cento, V, Antonucci, F.P, Di Paolo, D, Micheli, V, Tontodonati, M, De Leonardis, F, Niero, F, Di Maio, V.C, Aragri, M, Mancon, A, Francioso, S, Lenci, I, Nicolini, L.A, Marenco, S, Bertoli, A, Ursini, T, Polilli, E, Manunta, A, Tortora, A, Di Biagio, A, Nosotti, L, Sarrecchia, C, Viscoli, C, Siciliano, M, Landonio, S, Pellicelli, A, De Maria, A, Picciotto, A, Maida, I, Massari, M, Mastroianni, C, Mangia, A, Taliani, G, Gasbarrini, A, Vecchiet, J, Magni, C, Babudieri, S, Mura, M.S, Andreoni, M, Rizzardini, G, Parruti, G, Angelico, M, Perno, C.F, Ceccherini-Silberstein, F

Get full text

Hypothyroidism in HIV-Infected Patients Who Have or Have Not Received HAART by Quirino, T., Bongiovanni, M., Ricci, E., Chebat, E., Carradori, S., Martinelli, C., Valsecchi, L., Landonio, S., Bini, T., Bonfanti, P.

Get full text

Lopinavir/ritonavir treatment in HIV antiretroviral‐experienced patients: evaluation of risk factors for liver enzyme elevation by Meraviglia, P, Schiavini, M, Castagna, A, Viganò, P, Bini, T, Landonio, S, Danise, A, Moioli, MC, Angeli, E, Bongiovanni, M, Hasson, H, Duca, P, Cargnel, A

“…Objectives To evaluate the risk factors for lopinavir/ritonavir (LPV/r)‐related liver enzyme elevation (LEE) in HIV antiretroviral‐experienced patients…”
Get full text

The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study by Bonfanti, P., Pusterla, L., Parazzini, F., Libanore, M., Cagni, A.E., Franzetti, M., Faggion, I., Landonio, S., Quirino, T.

“…Our study was undertaken to evaluate if desensitization treatment is more effective than rechallenge in preventing hypersensitivity reactions in HIV-positive…”
Get full text

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients by Quirino, T, Niero, F, Ricci, E, Pusterla, L, Carradori, S, Gabbuti, A, Iemoli, E, Landonio, S, Faggion, I, Bonfanti, P

“…The aim of our study is to compare the tolerability of zidovudine/lamivudine/indinavir when used in post-exposure prophylaxis (PEP) subjects and in…”
Get full text

Predictors of protease inhibitor-associated adverse events by Bonfanti, P., Ricci, E., Landonio, S., Valsecchi, L., Timillero, L., Faggion, I., Quirino, T.

“…Risk factors in the development of adverse reactions in HIV-1-infected patients treated with highly active antiretroviral therapy (HAART) containing protease…”
Get full text

Osteonecrosis in protease inhibitor-treated patients by Bonfanti, P, Grabbuti, A, Carradori, S, Pusterla, L, Parrazini, F, Landonio, S, Quirino, T

“…The introduction of protease inhibitors has proven a watershed in human immunodeficiency virus infection therapy and has initiated an era of highly active…”
Get full text

THU-357 - What impact do the new direct acting antiviral drugs have on the patients’ quality of life? by Gentili, M., Magni, C.F., Carnovale, C., Cesari, E., Cattaneo, D., Schiavini, M., Landonio, S., Niero, F., Scalzi, V., Vimercati, S., Radice, S., Clementi, E., Rizzardini, G.

Get full text

What impact do the new direct acting antiviral drugs have on the patients’ quality of life? by Gentili, M., Magni, C.F., Carnovale, C., Cesari, E., Cattaneo, D., Schiavini, M., Landonio, S., Niero, F., Scalzi, V., Vimercati, S., Radice, S., Clementi, E., Rizzardini, G.

Get full text

FRI-211 - Direct Acting Antivirals in patients with HCV-associated mixed cryoglobulinemia: real life safety and efficacy by Rizzardini, G., Schiavini, M., Niero, F., Magni, C., Landonio, S., Iemoli, E., Bolis, M., Colaneri, M., Gubertini, G.

Get full text

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C by Di Maio, Velia Chiara, Barbaliscia, Silvia, Teti, Elisabetta, Fiorentino, Gianluca, Milana, Martina, Paolucci, Stefania, Pollicino, Teresa, Morsica, Giulia, Starace, Mario, Bruzzone, Bianca, Gennari, William, Micheli, Valeria, Yu La Rosa, Katia, Foroghi, Luca, Calvaruso, Vincenza, Lenci, Ilaria, Polilli, Ennio, Babudieri, Sergio, Aghemo, Alessio, Raimondo, Giovanni, Sarmati, Loredana, Coppola, Nicola, Pasquazzi, Caterina, Baldanti, Fausto, Parruti, Giustino, Perno, Carlo Federico, Angelico, Mario, Craxì, Antonio, Andreoni, Massimo, Ceccherini‐Silberstein, Francesca, Andreone, P, Aragri, M, Bertoli, A, Boeri, E, Brancaccio, G, Brunetto, M, Callegaro, AP, Cenderello, G, Cento, V, Ciaccio, A, Ciancio, A, Cuomo, N, De Santis, A, Di Biagio, A, Di Marco, V, Di Perri, G, Di Stefano, MA, Gaeta, GB, Ghisetti, V, Gulminetti, R, Lampertico, P, Landonio, S, Lichtner, M, Lleo, A, Maida, I, Marenco, S, Masetti, C, Mastroianni, C, Minichini, C, Milano, E, Monno, L, Novati, S, Pace Palitti, V, Paternoster, C, Pellicelli, A, Pieri, A, Puoti, M, Rizzardini, G, Ruggiero, T, Rossetti, B, Sangiovanni, V, Santantonio, T, Taliani, G, Toniutto, P, Vullo, V., Zazzi, M

“…Aim This study aimed to investigate the role of resistance‐associated substitutions (RASs) to direct‐acting‐antivirals (DAAs) in HCV genotype 3 (GT3). Methods…”
Get full text

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects by CATTANEO, Dario, GERVASONI, Cristina, MERAVIGLIA, Paola, LANDONIO, Simona, FUCILE, Serena, COZZI, Valeria, BALDELLI, Sara, PELLEGRINI, Michela, GALLI, Massimo, CLEMENTI, Emilio

“…Limited studies in healthy volunteers and in HIV-1-infected patients have shown that raltegravir pharmacokinetics are characterized by high inter-patient…”
Get full text